Navigation Links
Methamphetamine Confirmation/Quantitation, Urine

ProductsMethamphetamine Confirmation/Quantitation, Urine
Company ARUP Laboratories
Item Methamphetamine Confirmation/Quantitation, Urine
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. SureStep™ Drug Screen Tests - One-Step Immunoassays (Methamphetamine)
2. Methamphetamine - Rapid Test
3. Drugs of Abuse Confirmation/Quantitation-Amphetamine & Methamphetamine-Serum or Plasma
4. Drugs of Abuse Confirmation/Quantitation-Amphetamines (Amphetamine & Methamphetamine)-Meconium
5. Methamphetamine & Metabolite Confirmation/Quantitation, Meconium
6. SureStep Methamphetamines (MAMP)
7. SureStep Methamphetamines II (MAMP II)
8. 6-Acetylmorphine Confirmation/Quantitation, Urine
9. Alcohol Confirmation/Quantitation, Urine
10. Amphetamines Confirmation/Quantitation, Meconium
11. Amphetamines Confirmation/Quantitation, Urine
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture.
...provide superior tissue excision with precision-ma...pers offer an aggressive tooth pattern to capture ...nique stress pin buffering system to minimize tip ...ffering system applies increasing tension to the i...
Athroscopic leg holder system.
...er-pumps, the REVOLUTION provides continuous flow,...ermore the dual pump system gives the surgeon tota...ate. , ,The REVOLUTION system includes foot pedal ...y to increase flow while maintaining joint pressur...
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... called the H9N2 infection is reported in a nine m...Controller of the Center// for Health Protection o...s is the first of its kind in the past three years...y had fever from March 4 and she was hospitalized ...
...y come to the therapeutic aid of chronic lower bac...The School of Materials// and Professor Tony Freem.... The tiny gel particles discovered by the team a...jected into the damaged region. This study was per...
...ts that inflammation associated with the progressi...stasis of prostate cancer.// According to this r... San Diego (UCSD) School of Medicine "mounting an ...r body fight the cancer" may not be a good thing. ...
...at involves measuring the distance between the upp...lastic surgeons// use computer imaging software, a... facial proportions has been studied for centuries...d dentists,” the authors write as background infor...
Other Medicine News:Health News:Inflammation Promotes Metastasis of Prostate Cancer 2Health News:Inflammation Promotes Metastasis of Prostate Cancer 3Health News:Computer Imaging Assists With Facial Reconstructive Surgery 2
(Date:10/8/2008)... Reduce Animal Use in Cosmetics and Chemicals Test...k Corp. today announced,that results of a recently...-up" validation study on MatTek,s EpiDerm in vitro...monstrated the required sensitivity and,specificit...ative to animal,testing for determining human skin...
(Date:10/8/2008)... Program to be Discontinued and Headcount to be Re...s Portfolio Review; Zanolimumab Program to be Dis...f Employees, COPENH.../S (OMX: GEN),announced today that it is discontin... addition, as a result of a portfolio review and,a...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... 7 /- Prometheus Laboratories Inc., a... findings from its,development of PROMETHEUS(R) IB...ritable bowel syndrome (IBS). The findings suggest...cular biomarkers in blood samples,between IBS and ...arkers,combined with a proprietary algorithm, led...
Breaking Medicine Technology:MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Conscientious People Less Prone to Alzheimers 2508 1Conscientious People Less Prone to Alzheimers 2508 2Conscientious People Less Prone to Alzheimers 2508 3OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 1OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 2OPKO Health Appoints Pascal J Goldschmidt to Board of Directors 2506 3Todays 2008 Medicare Part B Premium Announcement is Not Good News 2504 1Todays 2008 Medicare Part B Premium Announcement is Not Good News 2504 2Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 1Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 2Regence Expands MedAdvantage Market Hits the Road to Educate Seniors 2502 3
...t Generation Renin Inhibitor to Continue Phase II ...and and BRIDGEWATER NJ/USA, 28 June 2007-Speedel,(...ther significant,milestone in the development of i...completion of a Phase IIa proof-of-concept clinica...ion. Based on these,positive results, the company ...
...KHAM, ON, June 28, 2007 /PRNewswire/ - Cytochroma ...clinical trial of,CTA018 Injection. The initial to...was safe and well tolerated. Complete study,result...leted Phase I trial was an open label,placebo-con...nistered to 20 healthy volunteers. In this trial, ...
Other Medicine Technology:Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 2Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 3Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 4Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 5Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 6Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 7Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension 8Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3